Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: A case-control study

Prostate

Volumn 70, Issue 15, 2010, Pages 1645-1657

  Safarinejad, Mohammad Reza ^a   Shafiei, Nayyer ^a   Safarinejad, Shiva ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene; Genetic; Methylenetetrahydrofolate reductase (MTHFR); Polymorphism; Prostate cancer

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; CYSTAMINE; DNA; DRUG DERIVATIVE; HOMOCYSTAMINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; EDUCATIONAL STATUS; FOLIC ACID BLOOD LEVEL; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; SMOKING; BLOOD; CHEMISTRY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; CYSTAMINE; DNA; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; VITAMIN B 12;

EID: 77958497609     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21200     Document Type: Article

References (52)

1. Choi SW, Mason JB,. Folate status: Effects on pathways of colorectal carcinogenesis. J Nutr 2002; 132 (8 Suppl): 2413S -2418S.
2. Goyette P, Pai A, Milos R,. Gene structure of human and mouse methylenetetrahydrofolate reductase. Mamm Genome 1998; 9: 652 -656.
3. Pintó X, Vilaseca MA, Garcia-Giralt N, Ferrer I, Palá M, Meco JF, Mainou C, Ordovás JM, Grinberg D, Baix Llobregat Homocysteine Study Group. Homocysteine and the risk of MTHFR 677C->T allele in premature coronary artery disease: Case control and family studies. Eur J Clin Invest 2001; 31: 24 -30.
4. Slattery ML, Edwards SL, Samowitz W, Potter J,. Associations between family history of cancer and genes coding for metabolizing enzymes (United States). Cancer Causes Control 2000; 11: 799 -803.
5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R,. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111 -113.
6. Friso S, Choi SW,. Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 2005; 6: 37 -46.
7. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK,. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas: A report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002; 107: 162 -168.
8. Robien K, Ulrich CM,. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: A HuGE minireview. Am J Epidemiol 2003; 157: 571 -582.
9. Neumann AS, Lyons HJ, Shen H, Liu Z, Shi Q, Sturgis EM, Shete S, Spitz MR, El-Naggar A, Hong WK, Wei Q,. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: A case-control analysis. Int J Cancer 2005; 115: 131 -136.
10. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis-Ellison R, Eckfeldt JH, Rozen R,. The 1298A > C polymorphism in methylenetetrahydrofolate reductase (MTHFR): In vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409 -415.
11. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom JH,. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044 -1051.
12. Thompson JR, Gerald PF, Willoughby MLN, Armstrong BK,. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukemia in childhood: A case-control study. Lancet 2001; 358: 1935 -1940.
13. Duthie SJ, Narayanan S, Blum S, Piric L, Brand G,. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal colon epithelial cells. Nutr Cancer 2000; 37: 245 -251.
14. Hubner RA, Houlston RS,. MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer 2007; 120: 1027 -1035.
15. Kim YI,. 5,10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: A new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease. Nutr Rev 2005; 63: 398 -407.
16. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE,. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22: 195 -201.
17. Kimura F, Franke KH, Steinhoff C, Golka K, Roemer HC, Anastasiadis AG, Schulz WA,. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate 2000; 45: 225 -231.
18. Heijmans BT, Boer JM, Suchiman HE, Cornelisse CJ, Westendorp RG, Kromhout D, Feskens EJ, Slagboom PE,. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 2003; 63: 1249 -1253.
19. Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS,. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 2004; 13: 1331 -1336.
20. Singal R, Ferdinand L, Das PM, Reis IM, Schlesselman JJ,. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int J Oncol 2004; 25: 1465 -1471.
21. Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D, Stefanovic M,. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: The Croatian case-control study. Clin Biochem 2007; 40: 981 -985.
22. Van Guelpen BR, Wirén SM, Bergh AR, Hallmans G, Stattin PE, Hultdin J,. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: A nested case-control study. Eur J Cancer Prev 2006; 15: 46 -50.
23. Lewontin RC,. On measures of gametic disequilibrium. Genetics 1988; 120: 849 -852.
24. Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ,. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 2002; 12: 339 -342.
25. Lievers KJ, Boers GH, Verhoef P, den Heijer M, Kluijtmans LA, van der Put NM, Trijbels FJ, Blom HJ,. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 2001; 79: 522 -528.
26. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R,. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzymatic activity. Mol Genet Metab 1998; 64: 169 -172.
27. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ,. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862 -4864.
28. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R,. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098 -1102.
29. Duthie SJ,. Folic acid deficiency and cancer: Mechanisms of DNA instability. Br Med Bull 1999; 55: 578 -592.
30. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN,. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94: 3290 -3295.
31. Sharp L, Little J,. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 2004; 159: 423 -443.
32. Song C, Xing D, Tan W, Wei Q, Lin D,. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001; 61: 3272 -3275.
33. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR, Wei Q,. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case-control study. Int J Cancer 2001; 95: 332 -336.
34. Campbell IG, Baxter SW, Eccles DM, Choong DY,. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 2002; 4: R14.
35. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, Le Marchand L, Selhub J, Murphy S, Donlon TA,. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 2001; 10: 1275 -1280.
36. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J,. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 1997; 18: 2307 -2311.
37. Levine AJ, Siegmund KD, Ervin CM, Diep A, Lee ER, Frankl HD, Haile RW,. The methylenetetrahydrofolate reductase 677C->T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 657 -663.
38. Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, Sinnett D,. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004; 103: 252 -257.
39. Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, Di Bona E, Rodeghiero F, Gilli G, Reverberi R, Caruso A, Pasello M, Pellati A, De Mattei M,. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 13: 787 -794.
40. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, Kondoh E, Maeda S, Asakura S, Kaba S, Nakamura S, Seto M, Morishima Y, Tajima K,. Association between polymorphisms of folate-and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001; 97: 205 -3209.
41. Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Oztürk O, Isbir T,. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct 2007; 25: 115 -117.
42. Paynter RA, Hankinson SE, Hunter DJ, De Vivo I,. No association between MTHFR 677 C->T or 1298 A->C polymorphisms and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13 (6): 1088 -1089.
43. Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, Gurgey A,. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 2003; 73: 154 -160.
44. Plaschke J, Schwanebeck U, Pistorius S, Saeger HD, Schackert HK,. Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Cancer Lett 2003; 191: 179 -185.
45. Frigola J, Sole X, Paz MF, Moreno V, Esteller M, Capella G, Peinado MA,. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet 2005; 14: 319 -326.
46. Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, Ward R,. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol 2003; 162: 1361 -1371.
47. Rozen R,. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 1996; 19: 589 -594.
48. Liu CS, Chen CH, Chiang HC, Kuo CL, Huang CS, Cheng WL, Wei YH, Chen HW,. B-group vitamins, MTHFR C677T polymorphism and carotid intima-Media thickness in clinically healthy subjects. Eur J Clin Nutr 2007; 61: 996 -1003.
49. Ulvik A, Ueland PM, Fredriksen A, Meyer K, Vollset SE, Hoff G, Schneede J,. Functional inference of the methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms from a large-scale epidemiological study. Hum Genet 2007; 1: 57 -64.
50. Alessio ACM, Annichino-Bizzacchi JM, Bydlowski SP, Eberlin MN, Vellasca AP, Hoehr NF,. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am J Med Genet 2004; 128A: 256 -260.
51. Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P,. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: A prospective study. Int J Cancer 2005; 113: 819 -824.
52. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG,. Replication validity of genetic association studies. Nat Genet 2001; 29: 306 -309.